| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 10-Q | Report | Data | 10-Q | Nov 7, 2024 | Sep 30, 2024 |
| 8-K | Report | Data | 8-K | Nov 7, 2024 | Nov 7, 2024 |
| SC 13G | Report | Nov 7, 2024 | ||
| SC 13D/A | Report | SC 13D/A | Oct 31, 2024 | |
| 8-K | Report | Data | 8-K | Oct 18, 2024 | Oct 16, 2024 |
| 8-K | Report | Data | 8-K | Oct 7, 2024 | Oct 1, 2024 |
| 8-K | Report | Data | 8-K | Sep 17, 2024 | Sep 15, 2024 |
| 8-K | Report | Data | 8-K | Sep 3, 2024 | Sep 3, 2024 |
| 10-Q/A | Report | Data | 10-Q/A | Aug 9, 2024 | Jun 30, 2024 |
| 10-Q | Report | Data | 10-Q | Aug 1, 2024 | Jun 30, 2024 |
| 8-K | Report | Data | 8-K | Aug 1, 2024 | Aug 1, 2024 |
| 8-K | Report | Data | 8-K | May 29, 2024 | May 23, 2024 |
| 8-K | Report | Data | 8-K | May 17, 2024 | May 3, 2024 |
| 10-Q | Report | Data | 10-Q | May 15, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | 8-K | May 15, 2024 | May 15, 2024 |
| 10-K | Report | Data | 10-K | Feb 22, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | 8-K | Feb 22, 2024 | Feb 21, 2024 |
| SC 13G | Report | SC 13G | Feb 14, 2024 | |
| 8-K | Report | Data | 8-K | Jan 8, 2024 | Jan 4, 2024 |
| SC 13D/A | Report | SC 13D/A | Dec 29, 2023 | |
| 10-Q | Report | Data | 10-Q | Nov 9, 2023 | Sep 30, 2023 |
| 8-K | Report | Data | 8-K | Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 10, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | Aug 10, 2023 | Aug 10, 2023 |
| SC 13G/A | Report | Jul 7, 2023 | ||
| 8-K | Report | Data | 8-K | May 22, 2023 | May 18, 2023 |
| 10-Q | Report | Data | 10-Q | May 11, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | 8-K | May 11, 2023 | May 11, 2023 |
| SC 13G | Report | SCHEDULE 13G | Apr 20, 2023 | |
| 10-K | Report | Data | 10-K | Mar 23, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | 8-K | Mar 23, 2023 | Mar 23, 2023 |
| SC 13G/A | Report | ATHIRA PHARMA, INC. | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 1, 2023 | ||
| SC 13G/A | Report | Jan 30, 2023 | ||
| 8-K | Report | Data | 8-K | Jan 6, 2023 | Jan 6, 2023 |
| 8-K | Report | Data | 8-K | Nov 18, 2022 | Nov 15, 2022 |
| 10-Q | Report | Data | 10-Q | Nov 10, 2022 | Sep 30, 2022 |
| 8-K | Report | Data | 8-K | Nov 10, 2022 | Nov 10, 2022 |
| 8-K | Report | Data | 8-K | Oct 17, 2022 | Oct 17, 2022 |
| 10-Q | Report | Data | 10-Q | Aug 15, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | 8-K | Aug 15, 2022 | Aug 15, 2022 |
| SC 13D/A | Report | SC 13D/A | Jul 1, 2022 | |
| 8-K | Report | Data | 8-K | Jun 22, 2022 | Jun 22, 2022 |
| 8-K | Report | Data | 8-K | May 24, 2022 | May 19, 2022 |
| 10-Q | Report | Data | 10-Q | May 12, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | 8-K | May 12, 2022 | May 12, 2022 |
| 10-K | Report | Data | 10-K | Mar 28, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | 8-K | Mar 24, 2022 | Mar 24, 2022 |
| 8-K | Report | Data | 8-K | Mar 21, 2022 | Mar 18, 2022 |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | ATHIRA PHARMA, INC. | Feb 14, 2022 | |
| SC 13G | Report | Feb 4, 2022 | ||
| SC 13G | Report | Feb 3, 2022 | ||
| 8-K | Report | Data | 8-K | Jan 31, 2022 | Jan 27, 2022 |
| 10-Q | Report | Data | 10-Q | Nov 10, 2021 | Sep 30, 2021 |
| 8-K | Report | Data | 8-K | Nov 10, 2021 | Nov 10, 2021 |
| 8-K | Report | Data | 8-K | Oct 21, 2021 | Oct 18, 2021 |
| 10-Q | Report | Data | 10-Q | Aug 16, 2021 | Jun 30, 2021 |
| 8-K | Report | Data | 8-K | Aug 16, 2021 | Aug 16, 2021 |
| 8-K | Report | Data | 8-K | Aug 9, 2021 | Aug 4, 2021 |
| 8-K | Report | Data | 8-K | Jun 21, 2021 | Jun 16, 2021 |
| 8-K | Report | Data | 8-K | Jun 1, 2021 | May 27, 2021 |
| 10-Q | Report | Data | 10-Q | May 13, 2021 | Mar 31, 2021 |
| 8-K | Report | Data | 8-K | May 13, 2021 | May 13, 2021 |
| 10-K | Report | Data | 10-K | Mar 25, 2021 | Dec 31, 2020 |
| 8-K | Report | 8-K | Mar 25, 2021 | Mar 25, 2021 |
| 8-K | Report | 8-K | Mar 8, 2021 | Mar 4, 2021 |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2021 | |
| SC 13G | Report | SC 13G | Feb 16, 2021 | |
| SC 13G/A | Report | AMENDMENT NO. 1 | Feb 16, 2021 | |
| SC 13G/A | Report | Feb 12, 2021 | ||
| SC 13D | Report | SC 13D | Feb 8, 2021 | |
| 8-K | Report | 8-K | Jan 11, 2021 | Jan 8, 2021 |
| 8-K | Report | 8-K | Dec 14, 2020 | Dec 11, 2020 |
| SC 13G | Report | SC 13G | Nov 16, 2020 | |
| 10-Q | Report | Data | 10-Q | Nov 12, 2020 | Sep 30, 2020 |
| 8-K | Report | 8-K | Nov 12, 2020 | Nov 12, 2020 |
| SC 13G | Report | ACQUISITION OF BENEFICIAL OWNERSHIP | Sep 28, 2020 | |
| SC 13G | Report | Sep 28, 2020 |